Challenges and Management of Acute Coronary Syndrome in Cancer Patients

被引：20

作者：

Costa, Isabela Bispo Santos da Silva ^{[1
]}

Andrade, Fernanda Thereza de Almeida ^{[1
]}

Carter, Diego ^{[2
]}

Seleme, Vinicius B. ^{[2
]}

Costa, Maycon Santos ^{[3
]}

Campos, Carlos M. ^{[2
]}

Hajjar, Ludhmila Abrahao ^{[1
,2
]}

机构：

[1] Univ Sao Paulo, Inst Canc, Sao Paulo, Brazil

[2] Univ Sao Paulo, Heart Inst InCor, Sch Med, Sao Paulo, Brazil

[3] Hosp Santana Mogi das Cruzes, Mogi Das Cruzes, SP, Brazil

来源：

FRONTIERS IN CARDIOVASCULAR MEDICINE | 2021年 / 8卷

关键词：

acute coronary syndrome; cancer; cardiotoxicity; coronary disease; cardio oncology; DUAL ANTIPLATELET THERAPY; ARTERIAL THROMBOEMBOLIC EVENTS; ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR TOXICITIES; CARDIO-ONCOLOGY; BREAST-CANCER; OUTCOMES; DISEASE; RISK; CHEMOTHERAPY;

D O I：

10.3389/fcvm.2021.590016

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cancer and cardiovascular disease are the leading causes of mortality in the world. The prevalence of cardiovascular risk factors and coronary artery disease in cancer patients is elevated, and it is associated with high mortality. Several mechanisms, such as the proinflammatory and procoagulant states present in cancer patients, may contribute to these scenarios. Oncological therapy can predispose patients to acute thrombosis, accelerated atherosclerosis and coronary spasm. Treatment decisions must be individualized and based on the cancer history and balancing bleeding and thrombosis risks.

引用

页数：9

共 64 条

[1] Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA [J].

Bharadwaj, Aditya ;

Potts, Jessica ;

Mohamed, Mohamed O. ;

Parwani, Purvi ;

Swamy, Pooja ;

Lopez-Mattei, Juan C. ;

Rashid, Muhammad ;

Kwok, Chun Shing ;

Fischman, David L. ;

Vassiliou, Vassilios S. ;

Freeman, Philip ;

Michos, Erin D. ;

Mamas, Mamas A. .

EUROPEAN HEART JOURNAL, 2020, 41 (23) :2183-+

[2] Cardiovascular Disease Mortality Among Breast Cancer Survivors [J].

Bradshaw, Patrick T. ;

Stevens, June ;

Khankari, Nikhil ;

Teitelbaum, Susan L. ;

Neugut, Alfred I. ;

Gammon, Marilie D. .

EPIDEMIOLOGY, 2016, 27 (01) :6-13

[3] Cardiovascular risk assessments in chronic myeloid leukemia allow identification of patients at high risk of cardiovascular events during treatment with nilotinib [J].

Breccia, Massimo ;

Colafigli, Gioia ;

Molica, Matteo ;

Alimena, Giuliana .

AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (05) :E100-E101

[4] Arterial Ischemic Events Are a Major Complication in Cancer Patients with Venous Thromboembolism [J].

Brenner, Benjamin ;

Bikdeli, Behnood ;

Tzoran, Inna ;

Madridano, Olga ;

Lopez-Reyes, Raquel ;

Maria Surinach, Jose ;

Blanco-Molina, Angeles ;

Tufano, Antonella ;

Lopez Nunez, Juan Jose ;

Trujillo-Santos, Javier ;

Monreal, Manuel .

AMERICAN JOURNAL OF MEDICINE, 2018, 131 (09) :1095-1103

[5] Arterial Thrombosis in Cancer: Spotlight on the Neglected Vessels [J].

Canale, Maria Laura ;

Bisceglia, Irma ;

Lestuzzi, Chiara ;

Parrini, Iris .

ANTICANCER RESEARCH, 2019, 39 (09) :4619-4625

[6] ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy JACC Guideline Comparison [J].

Capodanno, Davide ;

Alfonso, Fernando ;

Levine, Glenn N. ;

Valgimigli, Marco ;

Angiolillo, Dominick J. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (23) :2915-2931

[7] Angiogenesis Inhibitor Bevacizumab Increases the Risk of Ischemic Heart Disease Associated with Chemotherapy: A Meta-Analysis [J].

Chen, Xing-Lin ;

Lei, Ying-Hong ;

Liu, Cun-Fei ;

Yang, Qun-Fang ;

Zuo, Pei-Yuan ;

Liu, Cheng-Yun ;

Chen, Chang-Zhong ;

Liu, Yu-Wei .

PLOS ONE, 2013, 8 (06)

[8] Risk of Arterial Thromboembolic Events With Sunitinib and Sorafenib: A Systematic Review and Meta-Analysis of Clinical Trials [J].

Choueiri, Toni K. ;

Schutz, Fabio A. B. ;

Je, Youjin ;

Rosenberg, Jonathan E. ;

Bellmunt, Joaquim .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (13) :2280-2285

[9]

Collet JP, 2021, REV ESP CARDIOL, V74, DOI [10.1016/j.rec.2021.05.002, 10.1093/eurheartj/ehaa575]

[10] A Phase 2 Trial of Ponatinib in Philadelphia Chromosome-Positive Leukemias [J].

Cortes, J. E. ;

Kim, D. -W. ;

Pinilla-Ibarz, J. ;

le Coutre, P. ;

Paquette, R. ;

Chuah, C. ;

Nicolini, F. E. ;

Apperley, J. F. ;

Khoury, H. J. ;

Talpaz, M. ;

DiPersio, J. ;

DeAngelo, D. J. ;

Abruzzese, E. ;

Rea, D. ;

Baccarani, M. ;

Mueller, M. C. ;

Gambacorti-Passerini, C. ;

Wong, S. ;

Lustgarten, S. ;

Rivera, V. M. ;

Clackson, T. ;

Turner, C. D. ;

Haluska, F. G. ;

Guilhot, F. ;

Deininger, M. W. ;

Hochhaus, A. ;

Hughes, T. ;

Goldman, J. M. ;

Shah, N. P. ;

Kantarjian, H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (19) :1783-1796

← 1 2 3 4 5 6 7 →